Laboratory Workup for Patients with Memory Concerns
For patients presenting with memory concerns, a comprehensive laboratory workup should include thyroid-stimulating hormone (TSH), vitamin B12, folate, complete blood count, comprehensive metabolic panel, and glucose level as the essential first-tier tests. 1
Tiered Laboratory Assessment Approach
Tier 1 (Essential) Laboratory Tests:
- Complete blood count (CBC)
- Comprehensive metabolic panel
- Thyroid function tests (TSH, free T4)
- Vitamin B12 level
- Folate level
- Glucose level
These basic tests are critical for identifying common reversible causes of cognitive impairment and should be performed for all patients presenting with memory concerns 1.
Additional Tests Based on Clinical Suspicion:
- Serology for syphilis
- HIV testing
- Heavy metal screening
- Ammonia levels
- Antithyroid peroxidase and thyroglobulin antibodies (to assess for Hashimoto's Encephalopathy)
Neuroimaging Recommendations
Brain imaging is an essential component of the memory concerns workup:
- MRI of the brain is preferred to assess regional brain atrophy patterns, vascular injury, infarcts, microhemorrhages, and non-degenerative conditions 1
- CT may be used if MRI is contraindicated or unavailable
Cognitive Assessment Tools
Alongside laboratory testing, validated cognitive assessment tools should be used:
- Montreal Cognitive Assessment (MoCA): More sensitive than MMSE for mild cognitive impairment (12-15 minutes to administer)
- Mini-Mental State Examination (MMSE): Maps to dementia severity stages but lacks sensitivity for mild cognitive impairment
- Mini-Cog: Quick assessment (2-3 minutes) combining short-term memory assessment and Clock Drawing Test
- Geriatric Depression Scale (GDS): Important to screen for depression as a potential cause of cognitive symptoms
Emerging Blood-Based Biomarkers
While promising, blood-based biomarkers (BBMs) for Alzheimer's disease are not yet recommended for routine clinical use:
- BBMs should currently only be used in symptomatic patients at specialist clinics and results should be confirmed with CSF or PET when possible 2
- Additional research is needed before BBMs can be used as stand-alone diagnostic markers 2
- In primary care settings, current diagnostic workup typically includes basic blood tests (TSH, vitamin B12) and sometimes structural brain imaging 2
Clinical Considerations and Pitfalls
Common Pitfalls to Avoid:
- Overlooking depression: Depression can mimic cognitive impairment and should always be assessed 1
- Medication effects: Review all medications, particularly anticholinergics and sedatives that can impact cognition
- Missing reversible causes: Ensure thorough evaluation for potentially reversible causes including thyroid disorders, vitamin deficiencies, and metabolic abnormalities
- Inadequate neuroimaging: Cerebrovascular disease is often underdiagnosed clinically but frequently found on imaging 3
Important Clinical Insights:
- Laboratory abnormalities should be interpreted in clinical context - correction of abnormal lab values may not improve cognitive outcomes if neurodegenerative disease is present 3
- Subjective memory complaints may be influenced by psychosocial stress and anxiety, which should be assessed during evaluation 4
- The majority of older adults with memory complaints want to know their diagnosis, even if it's Alzheimer's disease 5
By following this structured laboratory and clinical assessment approach, clinicians can effectively evaluate patients with memory concerns and identify both reversible and irreversible causes of cognitive impairment.